Keymed Biosciences China California

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors

View original content:https://www.prnewswire.co.uk/news-releases/keymed-biosciences-announces-approval-of-ind-for-cm518d1-by-the-national-medical-products-administration-of-china-for-the-treatment-of-solid-tumors-302438248.html